<code id='F93B0E9E33'></code><style id='F93B0E9E33'></style>
    • <acronym id='F93B0E9E33'></acronym>
      <center id='F93B0E9E33'><center id='F93B0E9E33'><tfoot id='F93B0E9E33'></tfoot></center><abbr id='F93B0E9E33'><dir id='F93B0E9E33'><tfoot id='F93B0E9E33'></tfoot><noframes id='F93B0E9E33'>

    • <optgroup id='F93B0E9E33'><strike id='F93B0E9E33'><sup id='F93B0E9E33'></sup></strike><code id='F93B0E9E33'></code></optgroup>
        1. <b id='F93B0E9E33'><label id='F93B0E9E33'><select id='F93B0E9E33'><dt id='F93B0E9E33'><span id='F93B0E9E33'></span></dt></select></label></b><u id='F93B0E9E33'></u>
          <i id='F93B0E9E33'><strike id='F93B0E9E33'><tt id='F93B0E9E33'><pre id='F93B0E9E33'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:9289
          1:43Traders work on the floor of the New York Stock Exchange on July 12, 2023 in New York City.Spencer Platt/Getty Images

          As long-standing recession alarms continue to blare from some forecasters, investors don’t appear to hear them.

          The S&P 500 this year, when excluding the ten largest companies, stands at single-digit gains.

          Looking ahead, Agati and Moya said they expect the stock market to decline over the remainder of the year, ending 2023 with positive but modest returns. The full economic cooling-off effects of central bank rate hikes have yet to take hold, they said, adding that inflation may not return to normal levels as soon as investors hope.

          "The rally will stall out here," Moya said.

          MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

          Stoltzfus, however, said there's a "good chance" the stock market will end the year higher than it currently stands.

          "We have maintained a fairly bullish posture," he said. "Where the market is trading right now would suggest to us that it has further to go this year."

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal

          MollyFerguson/STATThisweek,IaddresspushbackIreceivedonmyNovartis-MorphoSyscolumn.Butfirst,apreviewof

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Judge rejects Trump's request to move Stormy Daniels hush

          0:31FormerPresidentDonaldTrumpspeaksattheConservativePoliticalActionConference,CPAC2023,March4,2023,